Curis Inc
CRISStock
$4.98−87.15%52W
Market Cap$8.97M
P/E—
Div yield—
Beta3.38
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-81.30%
Price vs S&P 500 (4W)-38.36%
VGM Score31.68
Market Capitalization$8.97M
Earnings Surprise History
Q1 26-1.25est. -0.41
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.10
4.10
4.10
4.10
Industry Peers — Biological Products(180)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CRISCuris Inc | B | F | F | $4.98 |
| AMGNAmgen Inc | C | C | C | $371.58 |
| GILDGilead Sciences Inc | C | B | C | $136.30 |
| ARGXargenx SE American Depositary Shares | D | A | B | $857.97 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $179.18 |
| BIIBBiogen Inc. Common Stock | B | D | B | $208.92 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.56 |
| MRNAModerna, Inc. Common Stock | D | B | B | $63.15 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $171.55 |
| EXELExelixis Inc | C | B | B | $55.68 |
| TECHBio-Techne Corp. | D | C | B | $71.77 |
About
Curis is a biotechnology company developing immuno-oncology and precision oncology therapies targeting solid tumors, diffuse large B-cell lymphoma, and hematological cancers. The company's pipeline includes five drug candidates: Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.